Ann & Robert H. Lurie Children’s Hospital of Chicago is the first in Illinois to receive designation as a NORD Rare Disease Center of Excellence, becoming one of 40 U.S. academic medical centers selected to be a part of the first-of-it-kind national network of U.S. medical institutions dedicated to diagnosing, treating, and researching all rare diseases.
Transgender and nonbinary youth experienced sustained improvements in depression and anxiety over two years after starting treatment with gender-affirming hormones, according to a recent study.
A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).
The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.
Ann & Robert H. Lurie Children’s Hospital of Chicago has recruited an internationally recognized surgeon-scientist, Thomas H. Inge, MD, PhD, as the hospital’s next surgeon-in-chief.
Todd Florin, MD, director of research for the Division of Emergency Medicine at Ann & Robert H. Lurie Children’s Hospital of Chicago and associate professor of Pediatrics, has been elected Strategy & Operations Officer at the Society for Pediatric Research.
The largest study to date of neurological manifestations of COVID-19 in children demonstrated patterns in the rare complications seen among pediatric patients.
Northwestern and Lurie Children’s Hospital investigators have been approved for a $4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study Lennox-Gastaut Syndrome.
The use of long-acting bronchodilators to treat asthma had no impact for some African-American children, according to a new study from Ann & Robert H. Lurie Children’s Hospital of Chicago and the Department of Pediatrics.
Thomas Shanley, MD, chair of Pediatrics, has been named as nominee for election as President and CEO of Ann & Robert H. Lurie Children’s Hospital of Chicago.
